Cargando…
Treatment with therapeutic anticoagulation is not associated with immunotherapy response in advanced cancer patients
BACKGROUND: Recent preclinical data suggest that there may be therapeutic synergy between immune checkpoint blockade and inhibition of the coagulation cascade. Here, we investigate whether patients who received immune checkpoint inhibitors (ICI) and were on concomitant anticoagulation (AC) experienc...
Autores principales: | Johannet, Paul, Sawyers, Amelia, Gulati, Nicholas, Donnelly, Douglas, Kozloff, Samuel, Qian, Yingzhi, Floristan, Alfredo, Hernando, Eva, Zhong, Judy, Osman, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847556/ https://www.ncbi.nlm.nih.gov/pubmed/33516263 http://dx.doi.org/10.1186/s12967-021-02712-w |
Ejemplares similares
-
Baseline prognostic nutritional index and changes in pretreatment body mass index associate with immunotherapy response in patients with advanced cancer
por: Johannet, Paul, et al.
Publicado: (2020) -
Clinical outcomes in cancer patients with COVID‐19
por: Sawyers, Amelia, et al.
Publicado: (2021) -
Revisiting the association between skin toxicity and better response in advanced cancer patients treated with immune checkpoint inhibitors
por: Gulati, Nicholas, et al.
Publicado: (2020) -
Preexisting immune‐mediated inflammatory disease is associated with improved survival and increased toxicity in melanoma patients who receive immune checkpoint inhibitors
por: Gulati, Nicholas, et al.
Publicado: (2021) -
Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade
por: Johannet, Paul, et al.
Publicado: (2022)